Connection

Raymond DuBois to Colorectal Neoplasms

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Colorectal Neoplasms.
Raymond DuBois
Connection Strength
10.539
Colorectal Neoplasms
  1. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas. Cancer Prev Res (Phila). 2022 05 03; 15(5):285-296.
    View in: PubMed
    Score: 0.542
  2. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer. Oncogene. 2021 10; 40(41):5984-5992.
    View in: PubMed
    Score: 0.516
  3. Prostaglandin E2 Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression. Gastroenterology. 2020 03; 158(4):971-984.e10.
    View in: PubMed
    Score: 0.457
  4. PPARd Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis. Cancer Res. 2019 09 01; 79(17):4480-4490.
    View in: PubMed
    Score: 0.445
  5. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017 07 01; 77(13):3655-3665.
    View in: PubMed
    Score: 0.383
  6. Kr?ppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1. PLoS One. 2016; 11(7):e0159899.
    View in: PubMed
    Score: 0.363
  7. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Gastroenterology. 2015 Dec; 149(7):1884-1895.e4.
    View in: PubMed
    Score: 0.340
  8. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014 Dec; 32(6):1105-1112.
    View in: PubMed
    Score: 0.317
  9. Peroxisome proliferator-activated receptor d promotes colonic inflammation and tumor growth. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):7084-9.
    View in: PubMed
    Score: 0.311
  10. Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc. 2014; 125:358-72; discussion 372-3.
    View in: PubMed
    Score: 0.304
  11. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013 Nov 11; 24(5):631-44.
    View in: PubMed
    Score: 0.301
  12. An inflammatory mediator, prostaglandin E2, in colorectal cancer. Cancer J. 2013 Nov-Dec; 19(6):502-10.
    View in: PubMed
    Score: 0.301
  13. HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Cancer Lett. 2013 Dec 01; 341(2):159-65.
    View in: PubMed
    Score: 0.296
  14. The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med. 2013; 64:131-44.
    View in: PubMed
    Score: 0.279
  15. Associations between obesity and cancer: the role of fatty acid synthase. J Natl Cancer Inst. 2012 Mar 07; 104(5):343-5.
    View in: PubMed
    Score: 0.267
  16. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011 Nov 15; 71(22):7010-20.
    View in: PubMed
    Score: 0.260
  17. Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer. J Biol Chem. 2011 Aug 26; 286(34):30003-9.
    View in: PubMed
    Score: 0.256
  18. Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterol Clin North Am. 2010 Sep; 39(3):697-707.
    View in: PubMed
    Score: 0.241
  19. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010 May 15; 70(10):4054-63.
    View in: PubMed
    Score: 0.236
  20. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res. 2010 Jan 15; 70(2):824-31.
    View in: PubMed
    Score: 0.231
  21. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs. Cancer Prev Res (Phila). 2009 Apr; 2(4):285-7.
    View in: PubMed
    Score: 0.219
  22. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008 Aug 28; 267(2):197-203.
    View in: PubMed
    Score: 0.205
  23. Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila). 2008 Jul; 1(2):93-9.
    View in: PubMed
    Score: 0.204
  24. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
    View in: PubMed
    Score: 0.197
  25. Inflammatory mediators and nuclear receptor signaling in colorectal cancer. Cell Cycle. 2007 Mar 15; 6(6):682-5.
    View in: PubMed
    Score: 0.190
  26. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res. 2006 Jul 01; 66(13):6649-56.
    View in: PubMed
    Score: 0.181
  27. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006 Apr 17; 203(4):941-51.
    View in: PubMed
    Score: 0.178
  28. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A. 2006 Jan 31; 103(5):1492-7.
    View in: PubMed
    Score: 0.175
  29. Connecting COX-2 and Wnt in cancer. Cancer Cell. 2006 Jan; 9(1):6-8.
    View in: PubMed
    Score: 0.175
  30. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 03; 281(5):2676-82.
    View in: PubMed
    Score: 0.173
  31. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology. 2005; 69 Suppl 1:28-32.
    View in: PubMed
    Score: 0.171
  32. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005 Apr 20; 23(12):2840-55.
    View in: PubMed
    Score: 0.166
  33. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005 Feb 04; 280(5):3217-23.
    View in: PubMed
    Score: 0.162
  34. Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer. J Biol Chem. 2005 Jan 07; 280(1):476-83.
    View in: PubMed
    Score: 0.161
  35. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep; 6(3):285-95.
    View in: PubMed
    Score: 0.159
  36. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004 May-Jun; 10(3):145-52.
    View in: PubMed
    Score: 0.156
  37. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
    View in: PubMed
    Score: 0.155
  38. Will an aspirin a day keep the endoscope away? Gastroenterology. 2003 Aug; 125(2):612-4.
    View in: PubMed
    Score: 0.148
  39. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res. 2003; 37:124-37.
    View in: PubMed
    Score: 0.142
  40. Controversy: PPARgamma as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2002 Aug; 283(2):G266-9.
    View in: PubMed
    Score: 0.138
  41. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91.
    View in: PubMed
    Score: 0.068
  42. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest. 2011 Nov; 121(11):4526-36.
    View in: PubMed
    Score: 0.065
  43. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol. 2009 Dec; 9(6):688-96.
    View in: PubMed
    Score: 0.056
  44. Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. J Clin Oncol. 2007 Jun 01; 25(16):2313-21.
    View in: PubMed
    Score: 0.048
  45. Cancer prevention: strategy for the future. Carcinogenesis. 2006 Jun; 27(6):1126-7.
    View in: PubMed
    Score: 0.045
  46. The COX-2 story: is any drug completely "safe?". Gastroenterology. 2006 Jan; 130(1):6.
    View in: PubMed
    Score: 0.044
  47. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1638-42.
    View in: PubMed
    Score: 0.041
  48. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem. 2003 Sep 12; 278(37):35451-7.
    View in: PubMed
    Score: 0.037
  49. New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity. Best Pract Res Clin Gastroenterol. 2002 Dec; 16(6):945-56.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.